PSH1 Antibody

What is PSH1 and why are antibodies against it valuable for research?

PSH1 (Priority in Synthesis of Histones 1) is an E3 ubiquitin ligase that specifically targets the centromeric histone variant Cse4 (CENP-A homolog) in budding yeast. PSH1 controls cellular levels of Cse4 through ubiquitylation and subsequent proteolysis, thereby preventing mislocalization of Cse4 to non-centromeric regions . PSH1 antibodies are invaluable research tools because they allow investigators to study the localization, interaction partners, and post-translational modifications of PSH1. These antibodies enable techniques such as immunoprecipitation, chromatin immunoprecipitation (ChIP), and western blotting, which have revealed that PSH1 localizes precisely at centromeric DNA sequences and interacts with kinetochore proteins . Without specific antibodies, many of the key discoveries about PSH1's role in centromere function would not have been possible, including the finding that PSH1 is present at centromeres throughout the cell cycle and that it physically interacts with Cse4 but not with histone H3, despite their sequence similarity .

What domains should be targeted when generating PSH1 antibodies?

When generating antibodies against PSH1, researchers should consider targeting regions outside the functionally important RING and zinc finger domains to avoid interference with protein function in experimental applications. PSH1 contains a RING finger domain (which includes residues H47 and C50) and a zinc finger domain (with residues C150 and C153), both of which are essential for its E3 ubiquitin ligase activity . The RING domain is particularly critical for physical interaction with Cse4, while both domains are required for PSH1-mediated degradation of Cse4 . Additionally, researchers should note that PSH1 contains multiple phosphorylation sites, primarily phosphorylated by Casein Kinase 2 (CK2), which modulate its activity . When designing immunogens for antibody production, researchers should consider unique regions of PSH1 that aren't highly conserved among other E3 ligases to ensure specificity. Epitope mapping experiments have shown that antibodies targeting the C-terminal region of PSH1 (beyond the functional domains) often yield good specificity while maintaining recognition of the native protein in various experimental applications.

What methods can effectively validate PSH1 antibody specificity?

Thorough validation of PSH1 antibodies requires multiple complementary approaches to ensure specificity and reliability in experimental applications. The gold standard for antibody validation is comparing signal between wild-type and psh1Δ strains using western blotting, which should show complete absence of signal in the deletion strain . Additionally, researchers should perform pre-adsorption tests where the antibody is pre-incubated with purified recombinant PSH1 protein before use in immunodetection; a specific antibody will show significantly reduced signal. For further validation, immunoprecipitation followed by mass spectrometry can confirm that the antibody is pulling down PSH1 and its known interacting partners such as Ubc8 (E2 enzyme) and components of the kinetochore . When validating PSH1 antibodies for chromatin immunoprecipitation experiments, researchers should confirm enrichment at all 16 centromeres, as demonstrated in previous studies . Finally, antibodies should be tested using Phos-tag SDS-PAGE to ensure they can detect both phosphorylated and non-phosphorylated forms of PSH1, particularly when studying PSH1 regulation by CK2 . This comprehensive validation approach ensures reliable results in various experimental contexts.

What are the optimal conditions for PSH1 detection in western blotting?

For optimal detection of PSH1 in western blotting, researchers should implement several critical technical considerations to maximize specificity and sensitivity. Cell lysis should be performed using buffers containing 50mM HEPES pH 7.9, 500mM NaCl, 2mM MgCl₂, 0.2% Triton X-100, 10% glycerol, and 0.5mM EDTA with protease inhibitors, as this formulation has been successfully used for PSH1 extraction . When studying PSH1 phosphorylation states, phosphatase inhibitors must be included in the buffer, and researchers should consider using Phos-tag SDS-PAGE, which enables separation of differentially phosphorylated PSH1 forms . Standard SDS-PAGE using 8-10% acrylamide gels effectively resolves PSH1 (~66 kDa), while transfer to PVDF membranes at 25V overnight at 4°C improves protein retention. For blocking, 5% non-fat dry milk in TBST for 1 hour at room temperature is recommended, although BSA may be preferable when detecting phosphorylated PSH1. Primary antibody incubation should be performed at 1:1000-1:5000 dilution (depending on the specific antibody) overnight at 4°C, followed by thorough washing with TBST. When analyzing PSH1 stability, cycloheximide chase assays have proven effective, with sample collection at 0, 30, 60, and 90 minutes following translation inhibition . These optimized conditions ensure consistent and reliable detection of PSH1 in western blotting experiments.

What immunoprecipitation protocols work best with PSH1 antibodies?

Effective immunoprecipitation of PSH1 requires careful optimization of extraction and binding conditions to maintain protein interactions while minimizing background. For whole-cell extract immunoprecipitation, cells should be lysed in buffer containing 50mM HEPES pH 7.9, 500mM NaCl, 2mM MgCl₂, 0.2% Triton X-100, 10% glycerol, and 0.5mM EDTA with protease inhibitors . When studying phosphorylated PSH1, phosphatase inhibitors (50mM NaF, 10mM sodium pyrophosphate, 1mM sodium orthovanadate) must be included . For chromatin-associated PSH1, researchers should prepare micrococcal nuclease (MNase)-solubilized chromatin as previously described by Camahort et al., which has successfully demonstrated the interaction between PSH1 and Cse4 . Antibodies should be conjugated to protein A/G magnetic beads rather than agarose beads, as this improves recovery and reduces background. For co-immunoprecipitation studies investigating PSH1 interactions with kinetochore proteins or CK2 subunits, a more gentle lysis buffer (25mM HEPES pH 7.5, 150mM NaCl, 0.1% NP-40, 10% glycerol) has proven effective . When eluting, non-denaturing conditions using competitive peptides are preferable if downstream functional assays are planned, while boiling in SDS sample buffer is suitable for analytical purposes. Including appropriate controls, such as IgG immunoprecipitation and 10% input samples, is essential for result interpretation.

How can PSH1 antibodies be used to study PSH1 phosphorylation states?

Studying PSH1 phosphorylation states requires specialized techniques that preserve and detect these post-translational modifications. Phos-tag SDS-PAGE is the preferred method for separating differentially phosphorylated forms of PSH1, as demonstrated in studies showing faster migration of dephosphorylated PSH1 compared to phosphorylated forms . When preparing samples, phosphatase inhibitors (50mM NaF, 10mM sodium pyrophosphate, 1mM sodium orthovanadate) must be included in all buffers to prevent dephosphorylation during extraction. Researchers should include both shrimp alkaline phosphatase (SAP)-treated and untreated samples as controls to identify phosphorylated bands . For immunoprecipitation of specific phosphorylated forms, researchers should first perform pilot experiments comparing wild-type PSH1 with samples from cka1Δ and cka2Δ strains, as Cka2 has been identified as the primary kinase responsible for PSH1 phosphorylation . Mass spectrometry analysis of immunoprecipitated PSH1 can identify specific phosphorylation sites, with previous studies identifying multiple sites with >20% modified/total spectra ratio . When performing western blotting, using both phospho-specific antibodies (if available) and total PSH1 antibodies on parallel blots provides the most complete picture of phosphorylation states. This approach has revealed that PSH1 phosphorylation by CK2 regulates its interaction with Cse4 and subsequent ubiquitylation activity.

What approaches ensure successful chromatin immunoprecipitation of PSH1?

Chromatin immunoprecipitation (ChIP) of PSH1 presents several technical challenges that must be addressed for successful experiments. First, formaldehyde crosslinking should be optimized at 1% for 15 minutes at room temperature, as PSH1's association with centromeric DNA is mediated through protein-protein interactions rather than direct DNA binding . Sonication should be carefully calibrated to produce fragments of 200-500bp, with chromatin fragmentation verified by agarose gel electrophoresis prior to immunoprecipitation. PSH1 antibodies must be validated specifically for ChIP applications, as some antibodies may perform well in western blotting but poorly in ChIP due to epitope masking by crosslinking . Previous studies have successfully used ChIP-chip and ChIP-qPCR to demonstrate that PSH1 localizes precisely at centromeric DNA sequences similar to Cse4 . For accurate centromere localization analysis, researchers should design primers spanning centromeric regions and flanking sequences (as shown in Figure 2B of reference 1). When analyzing cell cycle-dependent localization, synchronized cultures in G1 (using α-factor), S (using hydroxyurea), and G2/M (using nocodazole) phases have demonstrated that PSH1 localizes to centromeres throughout the cell cycle . Researchers should note that ChIP efficiency may be lower in G2/M arrested cultures due to reduced accessibility caused by assembled kinetochores . Including Cse4 ChIP as a positive control and measuring enrichment at all 16 centromeres ensures comprehensive analysis of PSH1 centromeric localization.

How can PSH1 antibodies be used to investigate PSH1-Cse4 interactions?

Investigating PSH1-Cse4 interactions requires specialized immunological approaches that preserve native protein complexes. Co-immunoprecipitation (co-IP) experiments have successfully demonstrated this interaction using both whole-cell extracts and micrococcal nuclease (MNase)-solubilized chromatin preparations . When performing co-IPs, researchers should use a dual epitope-tagged strain (Cse4-Myc/Psh1-HA) to facilitate detection of both proteins in complex . The interaction appears to be specific to Cse4, as PSH1 does not pull down histone H3 despite sequence similarity between Cse4 and H3 . To study the domains of PSH1 important for Cse4 interaction, researchers should compare wild-type PSH1 with RING finger mutants (H47A/C50A) and zinc finger mutants (C150A/C153A), as previous studies have shown that the RING finger domain is critical for physical interaction with Cse4 . For investigating how PSH1 phosphorylation affects its interaction with Cse4, researchers should compare wild-type PSH1 with samples from cka2Δ strains, as Cka2-mediated phosphorylation modulates PSH1 activity . When studying how the Cse4-specific chaperone Scm3 protects Cse4 from PSH1-mediated ubiquitylation, researchers can perform in vitro ubiquitylation assays with recombinant proteins and analyze by western blotting with anti-ubiquitin antibodies . These approaches have revealed that Scm3 may protect Cse4 from ubiquitylation, potentially explaining how Cse4 is maintained at centromeres despite the presence of PSH1.

What controls are necessary when studying PSH1-mediated ubiquitylation?

When studying PSH1-mediated ubiquitylation, researchers must implement comprehensive controls to ensure specificity and reliability of results. For in vitro ubiquitylation assays, essential components include recombinant E1, E2 (UbcH2/Ubc8), ubiquitin, ATP, and purified PSH1, with omission controls for each component . Substrate specificity controls should include testing PSH1 activity against histones H2A, H2B, H3, H4, and Scm3 alongside Cse4, as previous studies have demonstrated that PSH1 specifically ubiquitylates Cse4 but not other histones . When studying the domains required for PSH1 ubiquitin ligase activity, both RING finger mutants (H47A/C50A) and zinc finger mutants (C150A/C153A) should be compared to wild-type PSH1 . For analyzing ubiquitylation sites on Cse4, researchers should use mass spectrometry after in vitro ubiquitylation reactions, which has previously identified lysines 131, 155, 163, and 172 as primary ubiquitylation sites . To validate these sites in vivo, pulse-chase experiments comparing wild-type Cse4 with lysine-to-alanine mutants in both wild-type and psh1Δ backgrounds provide critical evidence of site-specific ubiquitylation . When examining how PSH1 phosphorylation affects its ubiquitylation activity, comparing ubiquitylation levels in wild-type versus cka2Δ strains is essential, as Cka2-mediated phosphorylation has been shown to facilitate PSH1 protein activity . These carefully designed controls ensure that observed ubiquitylation is specifically mediated by PSH1 and identify the regulatory mechanisms involved.

How can researchers differentiate between soluble and centromere-associated PSH1?

Differentiating between soluble and centromere-associated pools of PSH1 requires specialized subcellular fractionation techniques combined with appropriate immunodetection methods. Researchers should begin with a sequential extraction protocol that separates cytoplasmic, nucleoplasmic, and chromatin-bound fractions. First, spheroplasts should be prepared using zymolyase treatment, followed by gentle lysis in hypotonic buffer . Nuclei can be isolated by centrifugation and the cytoplasmic fraction retained. The nuclear pellet should then be extracted with nuclear lysis buffer containing 350mM NaCl to release soluble nuclear proteins . The remaining chromatin pellet contains chromatin-bound proteins including centromere-associated PSH1. For more refined analysis, this chromatin fraction can be treated with micrococcal nuclease (MNase) to release nucleosomal proteins while leaving kinetochore components in the insoluble fraction . Previous studies have shown that Psh1 is highly enriched in nuclear lysate, chromatin pellet, and MNase-insoluble pellet fractions, with minimal presence in the MNase-solubilized chromatin fraction containing mononucleosomes . This distribution pattern differs from Cse4, which is strongly detected in the MNase-solubilized chromatin fraction, suggesting PSH1 remains associated with kinetochore complexes rather than individual nucleosomes . Western blotting should include markers for each fraction (e.g., tubulin for cytoplasm, soluble nuclear proteins like Mcm2, and histone H3 for chromatin) to confirm fractionation quality. When studying cell cycle-dependent distribution, synchronized cultures in G1, S, and G2/M phases have shown that PSH1 levels in various fractions remain relatively constant throughout the cell cycle .

How can PSH1 antibodies be used in multi-protein complex analysis?

Multi-protein complex analysis involving PSH1 requires integrated approaches combining immunoprecipitation with advanced analytical techniques. Tandem affinity purification (TAP) of PSH1 followed by mass spectrometry has successfully identified interactions with canonical histones, Htz1, Cse4, and multiple kinetochore subcomplexes including the inner kinetochore protein Mif2, middle kinetochore COMA and MIND complexes, and components of the outer kinetochore . When performing such experiments, researchers should use crosslinking agents such as DSP (dithiobis(succinimidyl propionate)) at 0.5-2mM to stabilize transient protein interactions. For investigating whether PSH1 forms distinct complexes with different functional properties, size exclusion chromatography of nuclear extracts followed by western blotting with PSH1 antibodies can separate complexes by molecular weight. Blue native PAGE provides an alternative approach that maintains native protein interactions during electrophoresis. To identify which E2 ubiquitin-conjugating enzyme partners with PSH1, co-immunoprecipitation testing all nine yeast E2s (Ubc1-9) has demonstrated that only Ubc8 interacts with PSH1 . For studying interaction dynamics during the cell cycle, researchers should synchronize cultures and perform immunoprecipitation at different cell cycle stages. When analyzing post-translational modifications within these complexes, researchers should combine immunoprecipitation with phospho-specific antibodies or Phos-tag SDS-PAGE to determine how modifications affect complex formation . These approaches have revealed that PSH1 functions within distinct protein complexes at centromeres, providing mechanistic insights into its role in Cse4 regulation.

What methodological approaches can resolve contradictory data in PSH1 research?

Resolving contradictory data in PSH1 research requires systematic methodological approaches addressing potential sources of variability. First, researchers should consider strain background differences, as PSH1 function has been studied in various yeast strains (W303, S288C, etc.) that may exhibit subtle genetic differences affecting PSH1 activity . When contradictory results emerge regarding PSH1 localization, researchers should combine orthogonal techniques such as ChIP-seq, ChIP-qPCR, and immunofluorescence microscopy using multiple validated antibodies to provide convergent evidence . For discrepancies in PSH1-mediated Cse4 degradation, pulse-chase experiments should be conducted under precisely controlled conditions, including standardized cell densities and cycloheximide concentrations, as variations in these parameters can affect degradation kinetics . When contradictory results emerge regarding the role of specific lysines in Cse4 as ubiquitylation targets, researchers should note that previous studies have found that mutation of key lysines (131, 155, 163, and 172) stabilizes Cse4 in the presence of PSH1 but, interestingly, makes it less stable in psh1Δ strains, suggesting complex regulatory mechanisms . For resolving conflicts regarding PSH1 phosphorylation effects, researchers should combine in vivo approaches in cka1Δ and cka2Δ strains with in vitro kinase assays using purified components . When integrating data from different laboratories, researchers should pay particular attention to buffer compositions, as subtle differences in salt concentration or detergent can significantly affect protein interactions and enzymatic activities. These systematic approaches can help reconcile apparently contradictory findings and develop a coherent understanding of PSH1 function.

How should researchers design experiments to study novel PSH1 interacting proteins?

Designing robust experiments to identify and characterize novel PSH1 interacting proteins requires a multi-faceted approach combining discovery and validation techniques. For initial identification, researchers should perform immunoprecipitation of PSH1 from different cellular fractions (soluble nuclear extract, chromatin-bound, and MNase-resistant kinetochore fraction) followed by mass spectrometry analysis, as this approach has previously identified interactions with kinetochore components . To minimize false positives, researchers should implement quantitative proteomics approaches such as SILAC (Stable Isotope Labeling with Amino acids in Cell culture) comparing PSH1 immunoprecipitates with negative controls. Once candidate interactors are identified, validation should proceed through reciprocal co-immunoprecipitation experiments with epitope-tagged proteins, as demonstrated for the PSH1-Cse4 interaction . For further validation, proximity-based labeling techniques such as BioID or TurboID, where PSH1 is fused to a biotin ligase that biotinylates nearby proteins, can provide orthogonal evidence of interaction. Functional validation should include genetic interaction studies examining synthetic lethality or suppression between PSH1 and candidate interactors. When characterizing domain requirements for interactions, researchers should use the established RING finger (H47A/C50A) and zinc finger (C150A/C153A) mutants that have previously demonstrated differential effects on PSH1 function . To determine whether interactions are direct or indirect, researchers should perform in vitro binding assays with purified recombinant proteins. For examining how PSH1 phosphorylation affects these novel interactions, comparative analysis in wild-type versus cka2Δ strains provides valuable insights . This comprehensive approach ensures reliable identification and characterization of genuine PSH1 interacting proteins.

What methods enable accurate quantification of PSH1 enzymatic activity?

Accurate quantification of PSH1 enzymatic activity requires carefully optimized in vitro assays with stringent controls. Researchers should establish a reconstituted ubiquitylation system containing purified E1, the specific E2 partner Ubc8/UbcH2, recombinant PSH1, ATP regeneration system, and purified Cse4 substrate . Recombinant PSH1 should be expressed using baculovirus in Sf21 cells and purified via FLAG-tag affinity chromatography as previously described . For quantitative analysis, researchers should use fluorescently labeled ubiquitin (Ub-488) or biotinylated ubiquitin, allowing precise measurement of ubiquitylation kinetics through fluorescence intensity or ELISA-based detection, respectively. Reaction progress can be monitored by taking time-point samples (0, 5, 15, 30, 60 minutes) and analyzing by western blotting with anti-ubiquitin antibodies or by measuring fluorescence in plate reader format . Substrate specificity controls should include other histones and Scm3, which have been shown not to be ubiquitylated by PSH1 . To evaluate how phosphorylation affects PSH1 activity, researchers should compare wild-type PSH1 with protein treated with λ-phosphatase, or with PSH1 isolated from cka2Δ strains . For studying structure-function relationships, researchers should include the established RING finger (H47A/C50A) and zinc finger (C150A/C153A) mutants . Michaelis-Menten kinetic parameters (KM and kcat) should be determined using varying substrate concentrations, providing quantitative measures of enzymatic efficiency. These rigorously controlled assays enable accurate quantification of PSH1 activity and its regulation by post-translational modifications.

How can PSH1 antibodies facilitate studies of centromere assembly dynamics?

Studying centromere assembly dynamics using PSH1 antibodies requires integrating temporal analysis with spatial resolution of protein localization. Researchers should implement cell synchronization protocols using α-factor (G1), hydroxyurea (S-phase), and nocodazole (G2/M) followed by release and time-course sampling for ChIP-qPCR analysis of PSH1 and Cse4 at centromeric regions . Previous studies have shown that PSH1 localizes to centromeres throughout the cell cycle, though signal intensity may vary . For high-resolution analysis of PSH1 recruitment during centromere replication, researchers should synchronize cells at the G1/S boundary using α-factor followed by hydroxyurea, then release and perform chromatin immunoprecipitation at short intervals (5-10 minutes). Quantitative microscopy can complement biochemical approaches, using strains with fluorescently tagged Psh1 and Cse4 to monitor their dynamics in living cells. To study how PSH1-mediated proteolysis regulates Cse4 during centromere assembly, researchers should compare Cse4 levels and localization in wild-type and psh1Δ strains throughout the cell cycle . Conditional PSH1 depletion using auxin-inducible degron systems provides temporal control for examining immediate consequences of PSH1 loss on centromere assembly. For studying how phosphorylation of PSH1 affects centromere dynamics, researchers should compare wild-type cells with cka2Δ strains, as Cka2 is the primary kinase for PSH1 . Advanced techniques such as iPOND (isolation of Proteins On Nascent DNA) adapted for yeast can identify proteins at replication forks during centromere duplication. These integrated approaches have revealed that PSH1 plays a critical role in preventing mislocalization of Cse4 to non-centromeric regions, thereby maintaining centromere identity and function .

Future Directions in PSH1 Antibody-Based Research

The field of PSH1 antibody-based research is poised for significant advances through the integration of emerging technologies with established methodological approaches. Development of conformation-specific antibodies that distinguish between active and inactive states of PSH1 would enable direct visualization of PSH1 activation dynamics in response to cellular cues. Single-molecule imaging techniques combined with PSH1 antibodies could reveal the stoichiometry and assembly kinetics of PSH1-containing complexes at individual centromeres, providing unprecedented insights into spatial regulation. The application of proximity labeling approaches using PSH1 fused to engineered biotin ligases would enable comprehensive identification of the PSH1 interactome with spatial and temporal resolution. For investigating PSH1 regulation, the development of phospho-specific antibodies against the major phosphorylation sites would allow direct monitoring of how CK2-mediated phosphorylation affects PSH1 localization and activity . Adaptation of CRISPR-based genomic tagging for introducing minimal epitope tags will facilitate antibody-based detection while minimizing disruption of native protein function. Integration of these approaches with quantitative proteomics and structural biology will provide a comprehensive understanding of how PSH1 contributes to centromere specification and maintenance. These technological advances promise to resolve outstanding questions regarding the mechanisms that prevent Cse4 misincorporation at non-centromeric locations and how PSH1 activity is coordinated with other pathways regulating chromosome segregation.